Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus A Mall

Showing results (1-10 of 350) with videos related to

Pageof 35
Sort By:
Annals of the American Thoracic Society|April 27, 2016
Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseMarcus A Mall
The European Respiratory Journal|August 1, 2020
ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapiesMarcus A Mall
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 4, 2008
Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse modelsMarcus A Mall
Experimental Physiology|December 9, 2008
Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung diseaseMarcus A Mall
Pediatric Pulmonology|November 13, 2019
Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathwayAnita Balázs, Marcus A Mall
American Journal of Respiratory and Critical Care Medicine|July 16, 2014
A new player in the game: epithelial cathepsin S in early cystic fibrosis lung diseaseMarcus A Mall, Carsten Schultz
American Journal of Respiratory and Critical Care Medicine|January 4, 2018
Mucopurulent Triggering of the Airway Epithelium. Implications in Health and Cystic FibrosisAnita Balázs, Marcus A Mall
Chest|May 12, 2018
Ion Channel Modulators in Cystic FibrosisMartina Gentzsch, Marcus A Mall
The European Respiratory Journal|January 8, 2026
Pulmonary exacerbations in cystic fibrosis during the era of CFTR modulator therapyStephanie Thee, Marcus A Mall
The Journal of Physiology|May 5, 2025
Don't forget the mucus barrier in pulmonary drug delivery!Anita Balázs, Marcus A Mall
Pageof 35

Showing results (1-10 of 350) with videos related to

Sort By:
Pageof 35
Annals of the American Thoracic Society|April 27, 2016
Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseMarcus A Mall
The European Respiratory Journal|August 1, 2020
ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapiesMarcus A Mall
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 4, 2008
Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse modelsMarcus A Mall
Experimental Physiology|December 9, 2008
Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung diseaseMarcus A Mall
Pediatric Pulmonology|November 13, 2019
Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathwayAnita Balázs, Marcus A Mall
American Journal of Respiratory and Critical Care Medicine|July 16, 2014
A new player in the game: epithelial cathepsin S in early cystic fibrosis lung diseaseMarcus A Mall, Carsten Schultz
American Journal of Respiratory and Critical Care Medicine|January 4, 2018
Mucopurulent Triggering of the Airway Epithelium. Implications in Health and Cystic FibrosisAnita Balázs, Marcus A Mall
Chest|May 12, 2018
Ion Channel Modulators in Cystic FibrosisMartina Gentzsch, Marcus A Mall
The European Respiratory Journal|January 8, 2026
Pulmonary exacerbations in cystic fibrosis during the era of CFTR modulator therapyStephanie Thee, Marcus A Mall
The Journal of Physiology|May 5, 2025
Don't forget the mucus barrier in pulmonary drug delivery!Anita Balázs, Marcus A Mall
Pageof 35